XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia

Flavia Guillem, Michaël Dussiot, Elia Colin, Thunwarat Suriyun, Jean Benoit Arlet, Nicolas Goudin, Guillaume Marcion, Renaud Seigneuric, Sebastien Causse, Patrick Gonin, Marc Gastou, Marc Deloger, Julien Rossignol, Mathilde Lamarque, Zakia Belaid Choucair, Emilie Fleur Gautier, Sarah Ducamp, Julie Vandekerckhove, Ivan C. Moura, Thiago Trovati MacielCarmen Garrido, Xiuli An, Patrick Mayeux, Narla Mohandas, Geneviève Courtois, Olivier Hermine

    Résultats de recherche: Contribution à un journalArticleRevue par des pairs

    18 Citations (Scopus)

    Résumé

    β -thalassemia caused of hemoglobin, by a quantitative majorleading(β-TM)to defect theisaccumulation in an the inherited synthesis of freehemoglobinopathy of a β-globin -globin chains chains that aggregate and cause ineffective erythropoiesis. We have previously demonstrated that terminal erythroid maturation requires a transient activation of caspase-3 and that the chaperone Heat Shock Protein 70 (HSP70) accumulates in the nucleus to protect GATA-1 transcription factor from caspase-3 cleavage. This nuclear accumulation of HSP70 is inhibited in human β-TM erythroblasts due to HSP70 sequestration in the cytoplasm by free a-globin chains, resulting in maturation arrest and apoptosis. Likewise, terminal maturation can be restored by transduction of a nuclear-targeted HSP70 mutant.

    langue originaleAnglais
    Pages (de - à)2240-2249
    Nombre de pages10
    journalHaematologica
    Volume105
    Numéro de publication9
    Les DOIs
    étatPublié - 1 sept. 2020

    Contient cette citation